tiprankstipranks
Trending News
More News >
Cannabist Company Holdings Inc (TSE:CBST)
:CBST

Cannabist Company Holdings (CBST) AI Stock Analysis

Compare
52 Followers

Top Page

TS

Cannabist Company Holdings

(OTC:CBST)

Rating:39Underperform
Price Target:
C$0.50
▼(-10.71%Downside)
Cannabist Company Holdings is currently struggling with severe financial instability, highlighted by negative equity, high debt, and declining revenues, making financial performance a critical concern. Although there are efforts to restructure and optimize operations, these are overshadowed by ongoing liquidity and cash flow challenges. Technical analysis shows an overbought condition, adding further risk. The company's poor valuation metrics reflect its ongoing challenges.
Positive Factors
Expansion and Acquisitions
Verano set to expand operations in Arizona and enter Virginia via acquisitions with The Cannabist Co.
Financial Benefit
The transaction terms indicate potential financial benefit for CBST through cash and voting shares.
Negative Factors
Asset Dispositions
CBST progresses on previously announced planned asset dispositions.

Cannabist Company Holdings (CBST) vs. iShares MSCI Canada ETF (EWC)

Cannabist Company Holdings Business Overview & Revenue Model

Company DescriptionCannabist Company Holdings (CBST) is a diversified cannabis company that operates in multiple sectors of the cannabis industry, including cultivation, manufacturing, distribution, and retail. The company is committed to providing high-quality cannabis products and services to its customers and operates a range of dispensaries under the Cannabist brand. CBST's core products include a variety of cannabis strains, edibles, concentrates, and other related products tailored to both medical and recreational markets.
How the Company Makes MoneyCannabist Company Holdings makes money through several key revenue streams. The primary source of revenue is the sale of cannabis products through its retail dispensaries, where they offer a range of products including flowers, edibles, concentrates, and topicals. Additionally, the company generates income from its wholesale operations, supplying cannabis products to other dispensaries and businesses. CBST also benefits from its cultivation and manufacturing segments, which ensure a consistent supply of high-quality products and allow for vertical integration, reducing costs and increasing margins. Strategic partnerships and licensing agreements further enhance the company's revenue potential by expanding market reach and product offerings.

Cannabist Company Holdings Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q1-2025)
|
% Change Since: 0.00%|
Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed outlook with significant progress in debt restructuring and footprint optimization, but also highlighted challenges with revenue decline, negative cash flow, and liquidity constraints.
Q1-2025 Updates
Positive Updates
Debt Restructuring Approval
The company successfully received approval from over 75% of senior noteholders for the debt restructuring transaction, a crucial step towards improving financial stability.
Footprint Optimization Progress
The Cannabist Company made significant strides in footprint optimization by exiting underperforming markets such as Missouri, Utah, Puerto Rico, Washington D.C., Florida, and California, reducing active markets from 18 to 10.
New Store Openings and Brand Expansion
Opened a third dispensary in New Jersey; launched the 'dreamt' brand in Massachusetts, New Jersey, and Virginia, achieving notable success in Maryland.
Adjusted EBITDA Margin Improvement
The company reported an increase in adjusted EBITDA margin by more than 200 basis points sequentially to 9.5%, indicating slow but steady improvement.
Negative Updates
Revenue Decline
Q1 revenue was $87 million, a decrease of 9% from Q4, attributed to closures and sales of locations and challenging operational environments.
Negative Operating Cash Flow
The company reported negative operating cash flow of $15.4 million in Q1, impacted by a $9 million interest payment and other working capital challenges.
Wholesale Margin Pressure
Wholesale revenue increased by 3.5% sequentially, but margins declined due to pricing pressures and strategic divestitures.
Liquidity Concerns
Cash reserves fell to $18.9 million at the end of Q1, down from $33.6 million in Q4, highlighting ongoing liquidity challenges.
Company Guidance
During The Cannabist Company's First Quarter 2025 Earnings Conference Call, the company provided detailed guidance on its financial and operational strategies amid a challenging market environment. The call highlighted the successful approval of a debt restructuring transaction, which saw over 75% approval from senior noteholders, crucial for managing the upcoming maturity of $59.5 million of 6% senior secured notes due in June 2025. The company reported $87 million in revenue for Q1, with an adjusted EBITDA of $7.1 million and an adjusted EBITDA margin increase of over 200 basis points to 9.5%. Despite a challenging environment, the company achieved a 36% adjusted gross margin, up 50 basis points from the previous quarter. The Cannabist Company is actively optimizing its footprint, exiting several markets such as Washington, D.C., Florida, and California, and divesting underperforming assets. It maintains a focus on key markets like Colorado, Maryland, New Jersey, Ohio, and Virginia, and plans to open new stores in Ohio and Virginia in 2025. Furthermore, wholesale revenue increased by 3.5% sequentially, although wholesale gross margins declined, offset by improved retail gross margins. The company anticipates continued divestiture impacts and regulatory outcomes to influence future performance, with a projected mid- to high single-digit percent decline in revenue for Q2.

Cannabist Company Holdings Financial Statement Overview

Summary
Cannabist Company Holdings faces significant financial challenges with declining revenues, negative profitability, and a precarious balance sheet marked by negative equity and high debt. Cash flow issues further exacerbate the financial instability, posing a potential risk to long-term viability without significant restructuring or improvement in operational performance.
Income Statement
40
Negative
Cannabist Company Holdings has experienced a declining revenue trend, with a 17.2% decrease in total revenue from 2023 to TTM (Trailing-Twelve-Months). The gross profit margin stands at 35.0%, indicating some cost management, but the company faces significant challenges with profitability as indicated by a net loss and negative EBIT and EBITDA margins.
Balance Sheet
30
Negative
The company has a negative stockholders' equity of $-60.6 million, raising concerns about financial solvency. The debt-to-equity ratio is not calculable due to negative equity, and there is a significant amount of total debt at $464.4 million. These factors suggest a high-risk financial structure with limited equity buffer.
Cash Flow
35
Negative
Cannabist Company Holdings has a negative operating cash flow, indicating difficulty in generating cash from operations. Free cash flow remains negative, reflecting continued cash outflows exceeding cash inflows. The company appears reliant on external financing, which may not be sustainable.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
423.55M458.72M511.33M491.31M456.03M188.99M
Gross Profit
148.35M168.30M179.97M136.13M146.92M52.68M
EBIT
-19.70M-22.27M-105.24M-73.10M-37.70M-84.45M
EBITDA
17.63M28.61M-51.30M-282.36M-63.14M-115.66M
Net Income Common Stockholders
-103.02M-105.89M-175.71M-399.52M-141.84M-100.85M
Balance SheetCash, Cash Equivalents and Short-Term Investments
18.94M33.61M35.76M48.13M82.09M61.11M
Total Assets
648.78M696.17M823.11M994.28M1.37B727.53M
Total Debt
464.42M478.42M546.32M566.97M420.75M295.21M
Net Debt
445.48M444.81M510.56M518.84M338.66M234.10M
Total Liabilities
710.75M726.23M757.76M787.47M824.57M440.58M
Stockholders Equity
-60.61M-28.69M66.53M213.19M570.62M306.82M
Cash FlowFree Cash Flow
-39.26M-29.21M-2.50M-179.70M-132.64M-97.42M
Operating Cash Flow
-32.34M-23.38M7.47M-106.99M-518.40K-52.27M
Investing Cash Flow
31.32M30.98M-3.50M-72.34M-189.67M-24.02M
Financing Cash Flow
-24.95M-9.00M-14.12M147.59M200.66M90.00M

Cannabist Company Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.56
Price Trends
50DMA
0.56
Positive
100DMA
0.56
Negative
200DMA
0.56
Negative
Market Momentum
MACD
>-0.01
Neutral
RSI
100.00
Negative
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CBST, the sentiment is Negative. The current price of 0.56 is below the 20-day moving average (MA) of 0.56, above the 50-day MA of 0.56, and below the 200-day MA of 0.56, indicating a neutral trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CBST.

Cannabist Company Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSOGI
73
Outperform
C$239.65M17.824.76%26.93%
TSXLY
63
Neutral
$105.23M4.7618.60%26.78%
54
Neutral
$5.24B3.27-45.39%2.80%16.77%-0.07%
TSACB
50
Neutral
$405.59M33.594.78%16.39%-98.10%
48
Neutral
C$146.09M-38.89%-6.80%11.94%
47
Neutral
$367.57M-122.10%-16.27%
39
Underperform
C$227.80M-554.70%-14.45%44.87%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CBST
Cannabist Company Holdings
0.56
0.00
0.00%
TSE:WEED
Canopy Growth
2.31
-7.67
-76.85%
TSE:ACB
Aurora Cannabis
7.81
-0.31
-3.82%
TSE:XLY
Auxly Cannabis Group
0.08
0.05
128.57%
TSE:OGI
OrganiGram Holdings
1.86
-0.33
-15.30%
TSE:TSND
TerrAscend Corp
0.38
-1.63
-81.09%

Cannabist Company Holdings Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
The Cannabist Company Completes Strategic Financial Restructuring
Positive
May 30, 2025

The Cannabist Company Holdings Inc. has successfully completed a court-approved plan of arrangement, which involved exchanging existing senior secured notes for new senior notes due in 2028 and issuing new common shares and warrants to stakeholders. This strategic financial restructuring aims to enhance the company’s financial stability and operational flexibility, potentially strengthening its market position in the competitive cannabis industry.

The most recent analyst rating on (TSE:CBST) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Cannabist Company Holdings stock, see the TSE:CBST Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Cannabist Company Receives Court Approval for Strategic Arrangement
Positive
May 22, 2025

The Cannabist Company Holdings Inc. announced it has received court approval for its previously announced plan of arrangement under the Canada Business Corporations Act. This approval marks a significant step forward for the company, with the closing date targeted for May 29, 2025, pending regulatory approvals. The arrangement involves the issuance of new warrants to shareholders and is expected to impact the company’s operational structure and market positioning, enhancing its ability to deliver products and services across its network.

The most recent analyst rating on (TSE:CBST) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Cannabist Company Holdings stock, see the TSE:CBST Stock Forecast page.

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
The Cannabist Company Reports Q1 2025 Results Amid Strategic Restructuring
Neutral
May 8, 2025

The Cannabist Company reported a decrease in revenue for the first quarter of 2025, attributed to strategic closures and sales of underperforming locations. Despite the revenue drop, the company improved its gross margin and adjusted EBITDA margin through cost reduction and operational optimization. The company is undergoing a debt restructuring process and plans to further streamline its operations by divesting assets in Florida, California, and Illinois. The focus remains on liquidity, balance sheet management, and expanding retail operations in key markets.

Private Placements and FinancingM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
The Cannabist Company Reports Q1 2025 Results Amid Strategic Restructuring
Neutral
May 8, 2025

The Cannabist Company reported a decrease in revenue for the first quarter of 2025, attributed to strategic closures and divestitures aimed at simplifying operations and improving margins. The company is focusing on liquidity and operational improvements, with plans to open new retail locations in Ohio and Virginia, while preparing for the transition to adult use in Delaware. The approval of a debt restructuring transaction by Senior Note holders marks a significant step towards financial stability, pending court approval in Canada.

Private Placements and FinancingBusiness Operations and Strategy
Cannabist Company Secures Noteholder Approval for Financial Restructuring
Neutral
Apr 29, 2025

The Cannabist Company has received approval from its senior noteholders for a plan of arrangement that involves exchanging existing senior notes for new ones due in 2028 and issuing new common shares and warrants. This approval, which surpassed the required two-thirds majority, marks a significant step for the company, although the arrangement still requires court approval and faces opposition from a holder of the 2025 notes. The outcome of this arrangement could impact the company’s financial restructuring and its position in the cannabis industry.

Product-Related AnnouncementsBusiness Operations and Strategy
Cannabist Company Expands Adult-Use Cannabis Sales in New Jersey
Positive
Apr 22, 2025

The Cannabist Company has announced the launch of adult-use cannabis sales at its Mays Landing dispensary in New Jersey, marking its third location in the state. This expansion strengthens the company’s retail presence and supports its commitment to providing high-quality cannabis products to both medical and adult-use consumers. The grand opening event will feature promotions and a guest appearance by Ric Flair, enhancing community engagement and brand visibility. The company’s recent upgrades to its Vineland facilities further bolster its capacity to meet growing demand, positioning it favorably in the competitive cannabis market.

Business Operations and Strategy
Cannabist Company Holdings Announces Strategic Initiative to Boost Market Presence
Positive
Apr 8, 2025

Cannabist Company Holdings has announced a strategic initiative aimed at enhancing its market presence and operational efficiency. This move is expected to strengthen the company’s position in the cannabis industry by optimizing its resources and expanding its market reach, potentially benefiting stakeholders through improved performance and growth prospects.

Legal ProceedingsShareholder MeetingsBusiness Operations and Strategy
Cannabist Company Secures Interim Court Order for Strategic Arrangement
Neutral
Mar 31, 2025

The Cannabist Company announced that the Ontario Superior Court of Justice has granted an interim order for its plan of arrangement under the Canada Business Corporations Act. This plan involves the company and its subsidiaries, with a special meeting scheduled for Senior Noteholders to vote on the transaction. The transaction requires a two-thirds majority vote from Senior Noteholders and a final court order for approval. The outcome of this arrangement could significantly impact the company’s financial structure and market positioning.

Business Operations and StrategyFinancial Disclosures
The Cannabist Company Reports 2024 Financial Results Amid Strategic Transformation
Negative
Mar 13, 2025

The Cannabist Company reported a challenging financial performance for the fourth quarter and full year of 2024, with a decline in revenue and net income. Despite these results, the company is undergoing a transformation, implementing structural changes, and extending debt maturities to focus on optimizing operations and reducing costs. The company aims to simplify its business and improve financial performance in 2025, with plans to expand in Delaware, Virginia, and Ohio.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.